Results 231 to 240 of about 32,298 (248)
Some of the next articles are maybe not open access.
Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years
Nature Reviews Drug Discovery, 2010exaly
Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013
Journal of Medical Economics, 2010Lut Mergaert +2 more
exaly
Rare Diseases, Orphan Drugs, and Orphaned Patients
Molecular Interventions, 2006openaire +2 more sources
Rare diseases, orphan drugs and their regulation: questions and misconceptions
Nature Reviews Drug Discovery, 2010exaly
Access to orphan drugs – comparison across Balkan countries
Health Policy, 2018Georgi Iskrov +2 more
exaly
Challenges to orphan drugs access in Eastern Europe: The case of Bulgaria
Health Policy, 2012Tsonka Miteva-Katrandzhieva +2 more
exaly
The Economics of Drug Development: A Comparison between Orphan and Non-orphan Drugs
Current Drug Discovery TechnologiesSuchita P Dhamane
exaly

